According to Monte Rosa Therapeutics's latest financial reports the company's current earnings are โฌ42.95 Million. In 2025 the company made an earning of -โฌ34.64 Million, an increase over its 2024 earnings that were of -โฌ61.16 Million. The earnings displayed on this page is the company's Pretax Income.